Caligenix News
2 articles
growth-positive
Genetic Wellness Company, Caligenix to Launch Personalized Skincare and Nutrition Brands Leveraging Real-Time RNA
Caligenix announces the launch of two genomic-based wellness brands, Dermatype and Biotype, offering personalized skincare and nutrition products based on individual genomic DNA. The products utilize advanced technologies, AI algorithms, and genomics to provide consumers with insight into their unique needs and empower them to make positive changes. Dermatype offers an end-to-end skincare system with personalized serums based on stem cell technology, while Biotype focuses on personalized nutrition. Caligenix aims to personalize nutrition and skincare, allowing consumers to monitor the effects on their health. The company previously introduced Immunotype, a DNA-based supplement, and an Environmental Health Impact Index tool. The Dermatype and Biotype products are currently in trials.
CustomersPartners
growth-positive
Caligenix Enters Nutritional Supplement Space with Product Launch of Immunotype
Caligenix has launched Immunotype, a DNA-based supplement that addresses the human immune system at the level of the genome. The company aims to personalize nutrition and skincare using genomic technologies and actionable products. They have appointed Dr. Steve Henig as Chief Science Officer to lead the scientific team. Caligenix has been selected by leading multi-national CPG corporations for personalized nutrition pilots. The companys mission is to provide next-generation wellness supplements and skincare solutions based on individual genetic data.
CustomersInvestmentManagement Changes
